secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acurx Pharmaceuticals, Inc. (ACXP)
CIK:        0001736243
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001104659-23-072936
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acurx Pharmaceuticals stockholders approve officer exculpation amendment and reelect directors at annual meeting
--------------------------------------------------------------------------------

- Stockholders elected David P. Luci and Jack H. Dean as Class II directors with 5,749,190 and 5,575,112 votes for, respectively.
- Ratification of CohnReznick LLP as independent auditors for FY2023 approved with 9,016,668 votes for.
- Amendment to Certificate of Incorporation to allow officer exculpation under Delaware law approved with 6,054,547 votes for.
- Certificate of Amendment filed with Delaware Secretary of State on June 20, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736243/000110465923072936/0001104659-23-072936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736243/000110465923072936/tm2319191d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-072936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer